Case Type: Mergers & Acquisitions

SB One Bancorp (SBBX) relating to its sale to Provident Financial Services, Inc. Under the terms of the agreement, each share of SB One common stock will be converted into the right to receive 1.357 share of Provident common stock for each SB One common stock owned.

Tetraphase Pharmaceuticals, Inc. (TTPH) relating to its sale to AcelRx Pharmaceuticals, Inc. Under the terms of the agreement, each share of Tetraphase common stock will be converted into the right to receive 0.6303 of AcelRx common stock for each Tetraphase common stock owned.

TerraForm Power, Inc. (TERP) relating to its sale to Brookfield Renewable Power. Under the terms of the agreement, TerraForm shareholders will receive 0.381 of Brookfield Renewable units for each share of TerraForm common stock owned.

AVX Corporation (AVX) relating to its sale to Kyocera Corporation. Under the terms of the agreement, AVX shareholders will receive $21.75 for each share of AVX common stock owned.

QIAGEN N.V. (QGEN) related to its combination to Thermo Fisher Scientific Inc (“TMO”). Under the terms of the agreement, each share of QGEN will be purchased by TMO at a price of 39 Euros in cash for each QGEN common stock owned.

Willis Towers Watson PLC (WLTW) relating to its combination with Aon plc. Under the terms of the agreement, Willis Towers shareholders will be entitled to receive 1.08 newly issued Class A ordinary Aon share for each ordinary share of Willis Towers common stock owned.

The Meet Group, Inc. (MEET) related to its sale to ProsiebanSat.1 Media SE’s and General Atlantic’s joint company NCG NuCom Group SE. Under the terms of the agreement, each share of Meet Group common stock will be converted into the right to receive $6.30 in cash for each share of Meet Group common stock owned.

Mobile Mini, Inc. (MINI) related to its combination to WillScot Corporation. Under the terms of the agreement, Mobile Mini stockholders will receive 2.4050 shares of WillScot common stock for each share of Mobile Mini common stock owned.

Forty Seven, Inc. (FTSV) relating to its sale to Gilead Sciences, Inc. Under the terms of the agreement, Forty Seven shareholders will have the right to receive $95.50 for each share of Forty Seven common stock owned.

GAIN Capital Holdings, Inc. (GCAP) related to its sale to INTL FCStone, Inc. Under the terms of the agreement, each share of GAIN Capital common stock will be converted into the right to receive $6.00 in cash for each GAIN Capital common stock owned.